OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Extracellular binding sites of positive and negative allosteric P2X4 receptor modulators
Stephanie Weinhausen, Jessica Nagel, Vigneshwaran Namasivayam, et al.
Life Sciences (2022) Vol. 311, pp. 121143-121143
Closed Access | Times Cited: 14
Stephanie Weinhausen, Jessica Nagel, Vigneshwaran Namasivayam, et al.
Life Sciences (2022) Vol. 311, pp. 121143-121143
Closed Access | Times Cited: 14
Showing 14 citing articles:
Structural insights into the allosteric inhibition of P2X4 receptors
Cheng Shen, Yuqing Zhang, Wenwen Cui, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Cheng Shen, Yuqing Zhang, Wenwen Cui, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Species Differences of P2X4 Receptor Modulators
Jessica Nagel, Christiane Bous, Aliaa Abdelrahman, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access | Times Cited: 1
Jessica Nagel, Christiane Bous, Aliaa Abdelrahman, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access | Times Cited: 1
UB-MBX-46 is a potent and selective antagonist of the human P2X7 receptor developed by structure-based drug design
Adam Oken, Andreea L. Turcu, Eva Tzortzini, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Adam Oken, Andreea L. Turcu, Eva Tzortzini, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Identification of the molecular determinants of antagonist potency in the allosteric binding pocket of human P2X4
Gaia Pasqualetto, Marika Zuanon, Andrea Brancale, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Gaia Pasqualetto, Marika Zuanon, Andrea Brancale, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Ivermectin increases striatal cholinergic activity to facilitate dopamine terminal function
Hillary A. Wadsworth, Alicia M. P. Warnecke, Joshua C. Barlow, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Hillary A. Wadsworth, Alicia M. P. Warnecke, Joshua C. Barlow, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Preparation and preliminary evaluation of a tritium-labeled allosteric P2X4 receptor antagonist
Jessica Nagel, Olli Törmäkangas, Katja Kuokkanen, et al.
Purinergic Signalling (2024) Vol. 20, Iss. 6, pp. 645-656
Open Access | Times Cited: 2
Jessica Nagel, Olli Törmäkangas, Katja Kuokkanen, et al.
Purinergic Signalling (2024) Vol. 20, Iss. 6, pp. 645-656
Open Access | Times Cited: 2
Exploring P2X receptor activity: A journey from cellular impact to electrophysiological profiling
Calvin Dunker, Laura Vinnenberg, Andreas Isaak, et al.
Biochemical Pharmacology (2024), pp. 116543-116543
Open Access | Times Cited: 2
Calvin Dunker, Laura Vinnenberg, Andreas Isaak, et al.
Biochemical Pharmacology (2024), pp. 116543-116543
Open Access | Times Cited: 2
Fast green FCF prevents postoperative cognitive dysfunction via the downregulation of the P2X4 receptor in mice
Liu Jun, Tao Gao, Bin Zhou, et al.
International Immunopharmacology (2023) Vol. 121, pp. 110462-110462
Closed Access | Times Cited: 4
Liu Jun, Tao Gao, Bin Zhou, et al.
International Immunopharmacology (2023) Vol. 121, pp. 110462-110462
Closed Access | Times Cited: 4
Is there a biochemical basis for purinergic P2X3 and P2X4 receptor antagonists to be considered as anti-seizure medications?
Jeffrey M. Witkin, Hana Shafique, Jodi L. Smith, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116046-116046
Closed Access | Times Cited: 1
Jeffrey M. Witkin, Hana Shafique, Jodi L. Smith, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116046-116046
Closed Access | Times Cited: 1
Discovery of Triazolopyrimidine Derivatives as Selective P2X3 Receptor Antagonists Binding to an Unprecedented Allosteric Site as Evidenced by Cryo-Electron Microscopy
Garam Kim, Subin Kim, Yeo Ok Kim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 16, pp. 14443-14465
Closed Access | Times Cited: 1
Garam Kim, Subin Kim, Yeo Ok Kim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 16, pp. 14443-14465
Closed Access | Times Cited: 1
Structural insights into the allosteric inhibition of P2X4 receptors
Cheng Shen, Wenwen Cui, Yu‐Qing Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Cheng Shen, Wenwen Cui, Yu‐Qing Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Exploring P2x Receptor Activity: A Journey from Cellular Impact to Electrophysiological Profiling
Anna Junker, Calvin Dunker, Laura Vinnenberg, et al.
(2024)
Closed Access
Anna Junker, Calvin Dunker, Laura Vinnenberg, et al.
(2024)
Closed Access
Investigating cannabinoids as P2X purinoreceptor 4 ligands by using surface plasmon resonance and computational docking
Tess Puopolo, Ang Cai, Chang Liu, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21265-e21265
Open Access | Times Cited: 1
Tess Puopolo, Ang Cai, Chang Liu, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21265-e21265
Open Access | Times Cited: 1
Druggable site near the upper vestibule determines the high affinity and P2X3 homotrimer selectivity of sivopixant/S‐600918 and its analogue DDTPA
Dongping Wang, Meng Zhang, Ming Li, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 8, pp. 1203-1220
Closed Access | Times Cited: 1
Dongping Wang, Meng Zhang, Ming Li, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 8, pp. 1203-1220
Closed Access | Times Cited: 1
